Keynote Financial Services’s Celularity CELU Stock Holding History

Keynote Financial Services’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.9K	Buy	29,920 +600	+2%	+$576	0.01%	185
2026 Q1	$39K	Buy	29,320 +4,000	+16%	+$5.06K	0.02%	173
2025 Q4	$28.1K	Buy	25,320 +840	+3%	+$1.51K	0.02%	168
2025 Q3	$50.7K	Buy	24,480 +1,000	+4%	+$2.8K	0.03%	163
2025 Q2	$46K	Sell	23,480 -1,543	-6%	-$2.81K	0.03%	161
2025 Q1	$43.3K	Hold	25,023	–	–	0.03%	157
2024 Q4	$52K	Buy	25,023 +11,863	+90%	+$28.3K	0.04%	151
2024 Q3	$39.1K	Hold	13,160	–	–	0.03%	152
2024 Q2	$41.2K	Sell	13,160 -2,406	-15%	-$8.35K	0.03%	145
2024 Q1	$81.4K	Buy	+15,566	New	+$64K	0.07%	142

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Keynote Financial Services's CELU Position: Q2 2026 in Review

Keynote Financial Services increased its Celularity (CELU) stake by 2% in Q2 2026, buying an estimated $576 and bringing the position to 29,920 shares worth $17.9K. The position accounts for 0.01% of the portfolio, ranked #185.

Keynote Financial Services first reported a position in CELU in Q1 2024 and has held it in 10 quarters since. The position peaked at $81.4K in Q1 2024. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

Keynote Financial Services held 29,920 shares of Celularity worth $17.9K as of Q2 2026.
Keynote Financial Services bought 600 Celularity shares in Q2 2026, an estimated $576.
Celularity made up 0.01% of Keynote Financial Services's portfolio in Q2 2026, its #185 holding.
Keynote Financial Services first reported a position in Celularity in Q1 2024 and has held it in 10 quarters since.
Keynote Financial Services's Celularity position peaked at $81.4K in Q1 2024.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.